Market Overview:
The global malaria diagnostics market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of malaria, growing demand for rapid diagnostic tests (RDTs), and rising awareness about malaria diagnosis and treatment. In addition, the increasing funding for research on new diagnostic technologies is also contributing to the growth of this market. Based on type, the global malaria diagnostics market can be segmented into rapid diagnostic tests (RDTs), molecular diagnostics, and microscopy. The RDT segment is expected to account for the largest share of this market in 2018 owing to its high accuracy and fast turnaround time. By application, clinics accounted for the largest share of this market in 2017; however, hospitals are expected to grow at a higher rate during the forecast period due to rising demand for advanced diagnostic services.
Product Definition:
Malaria diagnostics is the process of detecting the presence of malaria parasites in a person's blood. It is an important tool for public health officials and clinicians to track and control malaria outbreaks. Malaria diagnostics can also help guide treatment decisions.
Rapid Diagnostic Tests (RDT):
Rapid diagnostic tests (RDTs) are used for the detection of diseases and infections. These tests are easy to use, highly sensitive, specific and accurate in nature. The major advantage of using an RDT is that it helps in detecting disease presence at the early stage when treatment with drugs may not be effective. This test can also be used for monitoring as well as diagnosing ongoing disease conditions especially during field work such as hospital visits or while collecting blood samples from patients or animals.
Molecular Diagnostics:
Molecular diagnostics is a set of procedures used to identify and analyze genetic material (DNA & RNA) of infectious agents such as bacteria, viruses, fungus & parasites. It also helps in determining the type of infection an individual suffers from. This aids in the development of specific treatment for that particular disease.
Application Insights:
The market is segmented by application into clinics, hospitals and laboratories. The clinics segment dominated the overall market in terms of revenue in 2017 owing to high usage rates of rapid diagnostic tests for malaria among patients and increasing government funding for the distribution and installation of RDTs at community health centers (CHCs). CHC is a primary healthcare facility that provides diagnosis-related information to patients within a short time period. CHCs are expected to be one of the prominent end users due to their accessibility as well as their ability provide sensitive care along with effective treatment.
Malaria parasites can be detected from blood or other body fluids using microscopy, which requires skilled technicians and laboratory resources. This has led to an increase in demand for advanced diagnostics systems that not only detect parasite infection but also identify specific antigens associated with them, especially during severe disease stages when parasitemia occurs frequently even after completion of chemotherapy treatments.
Regional Analysis:
Asia Pacific dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing funding for malaria control and prevention programs, growing target population base, and rising incidence rates of malaria. In addition, increasing number of R&D activities by various organizations in this region is anticipated to fuel the growth of the regional market over the forecast period.
The Asia Pacific has one of highest malarial transmission zones worldwide with an estimated 90%+ infection rate across key countries such as India, Indonesia & Malaysia (IMM). IMM has one of highest burden rates with approximately 4 million cases annually across peninsular Malaysia and another 2 million cases annually across Sumatra island-province which includes western Indonesia (source: World Malaria Report 2018). Thus; these are some factors that can be attributed towards dominance of Asia Pacific within global arena throughout this study.
Growth Factors:
- Increasing incidence of malaria: The global incidence of malaria is increasing due to the increase in international travel and trade, population growth and urbanization. According to the World Health Organization (WHO), there were an estimated 214 million cases of malaria in 2015, resulting in 438,000 deaths. This number is projected to grow to about 216 million cases and 445,000 deaths by 2020.
- Unmet needs for accurate diagnosis: There are a number of unmet needs for accurate diagnosis including lack of access to diagnostic services in rural areas and low-income countries; limited availability or use of rapid diagnostic tests (RDTs) that can provide results within minutes; misdiagnosis due to lack of laboratory capacity or poor quality laboratory services; and incorrect treatment decisions based on inaccurate test results.
- Growing demand for point-of-care diagnostics: The growing demand for point-of-care diagnostics is driven by the need for timely diagnosis so that patients can receive appropriate treatment as soon as possible. This has led to an increased demand for RDTs which can provide results within minutes instead of hours or days required by traditional laboratory methods such as microscopy examination..
Scope Of The Report
Report Attributes
Report Details
Report Title
Malaria Diagnostics Market Research Report
By Type
Rapid Diagnostic Tests (RDT), Molecular Diagnostics, Microscopy
By Application
Clinics, Hospitals, Laboratories
By Companies
Abbott Laboratories, Beckman Coulter/Danaher, Bio-Rad Laboratories, Inc., Life Technology, Novartis Diagnostics., Ltd., Ortho-Clinical Diagnostics, Premier Medical Corporation Ltd., Siemens Healthcare, Wako Chemicals, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
216
Number of Tables & Figures
152
Customization Available
Yes, the report can be customized as per your need.
Global Malaria Diagnostics Market Report Segments:
The global Malaria Diagnostics market is segmented on the basis of:
Types
Rapid Diagnostic Tests (RDT), Molecular Diagnostics, Microscopy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinics, Hospitals, Laboratories
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Beckman Coulter/Danaher
- Bio-Rad Laboratories, Inc.
- Life Technology
- Novartis Diagnostics., Ltd.
- Ortho-Clinical Diagnostics
- Premier Medical Corporation Ltd.
- Siemens Healthcare
- Wako Chemicals, Inc.
Highlights of The Malaria Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Rapid Diagnostic Tests (RDT)
- Molecular Diagnostics
- Microscopy
- By Application:
- Clinics
- Hospitals
- Laboratories
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Malaria Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Malaria Diagnostics is a company that provides diagnostic services for malaria. Its products include tests to determine whether someone has malaria and other related information.
Some of the key players operating in the malaria diagnostics market are Abbott Laboratories, Beckman Coulter/Danaher, Bio-Rad Laboratories, Inc., Life Technology, Novartis Diagnostics., Ltd., Ortho-Clinical Diagnostics, Premier Medical Corporation Ltd., Siemens Healthcare, Wako Chemicals, Inc..
The malaria diagnostics market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Malaria Diagnostics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Malaria Diagnostics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Malaria Diagnostics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Malaria Diagnostics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Malaria Diagnostics Market Size & Forecast, 2018-2028
4.5.1 Malaria Diagnostics Market Size and Y-o-Y Growth
4.5.2 Malaria Diagnostics Market Absolute $ Opportunity
Chapter 5 Global Malaria Diagnostics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Malaria Diagnostics Market Size Forecast by Type
5.2.1 Rapid Diagnostic Tests (RDT)
5.2.2 Molecular Diagnostics
5.2.3 Microscopy
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Malaria Diagnostics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Malaria Diagnostics Market Size Forecast by Applications
6.2.1 Clinics
6.2.2 Hospitals
6.2.3 Laboratories
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Malaria Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Malaria Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Malaria Diagnostics Analysis and Forecast
9.1 Introduction
9.2 North America Malaria Diagnostics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Malaria Diagnostics Market Size Forecast by Type
9.6.1 Rapid Diagnostic Tests (RDT)
9.6.2 Molecular Diagnostics
9.6.3 Microscopy
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Malaria Diagnostics Market Size Forecast by Applications
9.10.1 Clinics
9.10.2 Hospitals
9.10.3 Laboratories
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Malaria Diagnostics Analysis and Forecast
10.1 Introduction
10.2 Europe Malaria Diagnostics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Malaria Diagnostics Market Size Forecast by Type
10.6.1 Rapid Diagnostic Tests (RDT)
10.6.2 Molecular Diagnostics
10.6.3 Microscopy
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Malaria Diagnostics Market Size Forecast by Applications
10.10.1 Clinics
10.10.2 Hospitals
10.10.3 Laboratories
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Malaria Diagnostics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Malaria Diagnostics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Malaria Diagnostics Market Size Forecast by Type
11.6.1 Rapid Diagnostic Tests (RDT)
11.6.2 Molecular Diagnostics
11.6.3 Microscopy
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Malaria Diagnostics Market Size Forecast by Applications
11.10.1 Clinics
11.10.2 Hospitals
11.10.3 Laboratories
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Malaria Diagnostics Analysis and Forecast
12.1 Introduction
12.2 Latin America Malaria Diagnostics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Malaria Diagnostics Market Size Forecast by Type
12.6.1 Rapid Diagnostic Tests (RDT)
12.6.2 Molecular Diagnostics
12.6.3 Microscopy
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Malaria Diagnostics Market Size Forecast by Applications
12.10.1 Clinics
12.10.2 Hospitals
12.10.3 Laboratories
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Malaria Diagnostics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Malaria Diagnostics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Malaria Diagnostics Market Size Forecast by Type
13.6.1 Rapid Diagnostic Tests (RDT)
13.6.2 Molecular Diagnostics
13.6.3 Microscopy
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Malaria Diagnostics Market Size Forecast by Applications
13.10.1 Clinics
13.10.2 Hospitals
13.10.3 Laboratories
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Malaria Diagnostics Market: Competitive Dashboard
14.2 Global Malaria Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Beckman Coulter/Danaher
14.3.3 Bio-Rad Laboratories, Inc.
14.3.4 Life Technology
14.3.5 Novartis Diagnostics., Ltd.
14.3.6 Ortho-Clinical Diagnostics
14.3.7 Premier Medical Corporation Ltd.
14.3.8 Siemens Healthcare
14.3.9 Wako Chemicals, Inc.
